Stock PANJON PANJON LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Panjon Limited

Equities

PANJON

INE744D01019

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:57 2024-07-02 EDT 		5-day change 1st Jan Change
19.38 INR +0.73% Intraday chart for Panjon Limited +3.19% +10.24%
05-27 Panjon Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
05-27 Panjon Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2021 2022 2023
Capitalization 1 117.3 117.3 272.8 180.9
Enterprise Value (EV) 1 132.5 127.4 266.5 174
P/E ratio 96.2 x 122 x -6.57 x 22.3 x
Yield - - - -
Capitalization / Revenue 0.58 x 0.81 x 3.23 x 2.97 x
EV / Revenue 0.66 x 0.88 x 3.16 x 2.86 x
EV / EBITDA 54.4 x 67.4 x -6.59 x -2,620 x
EV / FCF -64 x - 25.8 x -9.91 x
FCF Yield -1.56% - 3.88% -10.1%
Price to Book 0.71 x 0.69 x 2.15 x 1.34 x
Nbr of stocks (in thousands) 15,499 15,499 15,499 15,499
Reference price 2 7.570 7.570 17.60 11.67
Announcement Date 18-05-30 22-09-16 22-09-16 23-09-06
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2021 2022 2023
Net sales 1 201 145.4 84.32 60.91
EBITDA 1 2.435 1.891 -40.45 -0.0664
EBIT 1 1.361 -0.3622 -42.48 -2.176
Operating Margin 0.68% -0.25% -50.38% -3.57%
Earnings before Tax (EBT) 1 2.436 1.925 -40.15 1.178
Net income 1 1.219 0.9625 -41.52 8.101
Net margin 0.61% 0.66% -49.24% 13.3%
EPS 2 0.0787 0.0620 -2.679 0.5227
Free Cash Flow 1 -2.071 - 10.35 -17.55
FCF margin -1.03% - 12.27% -28.81%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 18-05-30 22-09-16 22-09-16 23-09-06
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2021 2022 2023
Net Debt 1 15.2 10.1 - -
Net Cash position 1 - - 6.26 6.9
Leverage (Debt/EBITDA) 6.227 x 5.346 x - -
Free Cash Flow 1 -2.07 - 10.3 -17.6
ROE (net income / shareholders' equity) 0.74% - -28.2% 6.2%
ROA (Net income/ Total Assets) 0.46% - -15.9% -0.94%
Assets 1 264 - 260.3 -862.1
Book Value Per Share 2 10.70 11.00 8.170 8.700
Cash Flow per Share 2 0.2400 0.2000 0.9300 0.9500
Capex 1 0.82 0.66 1.86 1.76
Capex / Sales 0.41% 0.46% 2.2% 2.89%
Announcement Date 18-05-30 22-09-16 22-09-16 23-09-06
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PANJON LIMITED Stock Panjon Limited
+10.24% 3.76M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+56.86% 823B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.19% 641B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.57% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.32% 324B
ABBVIE INC. Stock AbbVie Inc.
+9.94% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.28% 241B
ROCHE HOLDING AG Stock Roche Holding AG
+1.60% 223B
NOVARTIS AG Stock Novartis AG
+13.30% 218B
AMGEN INC. Stock Amgen Inc.
+7.98% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PANJON Stock
  4. Financials Panjon Limited